会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 43. 发明授权
    • Compositions and methods relating to reduction of symptoms of autism
    • 与减少自闭症症状有关的组成和方法
    • US06899876B2
    • 2005-05-31
    • US10313338
    • 2002-12-06
    • Devin B. Houston
    • Devin B. Houston
    • A61K38/00A61K38/48C12N9/02C12N9/48C12N9/62
    • C12N9/48A61K38/4813C12N9/0059C12Y110/03001C12Y304/14005A61K2300/00
    • Methods and compositions that can reduce the symptoms of autism in a human patient comprising administering a physiologically effective amount of one or both of a purified casomorphin inhibitor selected from the group consisting of a casomorphinase and a casomorphin ligand, and a physiologically effective amount of a purified gluteomorphin inhibitor selected from the group consisting of a gluteomorphinase and a gluteomorphin ligand, to a human patient in sufficient quantities to reduce the effects of the autism. In some embodiments, the compositions and methods further comprise a physiologically effective amount of an enkephalin inhibitor, preferably an enkephalinase, and a physiologically effective amount of an endorphin inhibitor, preferably an endorphinase.
    • 可以减轻人类患者自闭症症状的方法和组合物,其包括给予生理学有效量的选自下列药物的一种或两种纯化的casomorphin抑制剂:胱天肽酶和casomorphin配体,以及生理有效量的纯化 麝香草素抑制剂,选自糠醛吗啡酶和钆蓝霉素配体,以足够的量向人类患者减轻自闭症的作用。 在一些实施方案中,组合物和方法还包含生理有效量的脑啡肽抑制剂,优选脑啡肽酶和生理有效量的内啡肽抑制剂,优选内啡肽。